These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25322075)

  • 81. Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?
    Liccardi G; Calzetta L; Salzillo A; Piccolo A; Pane G; Rogliani P
    Expert Opin Pharmacother; 2017 Jun; 18(8):833-835. PubMed ID: 28399659
    [No Abstract]   [Full Text] [Related]  

  • 82. NHLBI ASTHMA NETWORKS: IMPROVING PATIENT CARE, MOVING TOWARD PERSONALIZED MEDICINE.
    Peters SP
    Trans Am Clin Climatol Assoc; 2022; 132():44-60. PubMed ID: 36196171
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Can tiotropium add-on therapy safely improve clinical outcomes in children and adolescents with persistent asthma?
    Yang D; Peng Q; Huang T; Guo X; Liu C
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):109-110. PubMed ID: 32371245
    [No Abstract]   [Full Text] [Related]  

  • 84. The importance of considering safety data from large-scale clinical trials in patients with asthma.
    Dahl R
    Chest; 2015 May; 147(5):e195. PubMed ID: 25940270
    [No Abstract]   [Full Text] [Related]  

  • 85. Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies.
    Jenkins C
    Ther Clin Risk Manag; 2019; 15():423-435. PubMed ID: 30936705
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience.
    Ridha Z; Bédard MA; Smyrnova A; Drouin O; Pruteanu A; Essouri S; Ducharme FM
    Allergy Asthma Clin Immunol; 2021 Dec; 17(1):129. PubMed ID: 34895321
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Response.
    Rodrigo GJ; Castro-Rodríguez JA
    Chest; 2015 May; 147(5):e196. PubMed ID: 25940271
    [No Abstract]   [Full Text] [Related]  

  • 88. The role of tiotropium in the management of asthma.
    Park HW
    Asia Pac Allergy; 2012 Apr; 2(2):109-14. PubMed ID: 22701860
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pooled studies can raise misleading alarm bells, regulators say.
    Scudellari M
    Nat Med; 2010 Oct; 16(10):1051. PubMed ID: 20930720
    [No Abstract]   [Full Text] [Related]  

  • 90. Reimagining Cost-Effectiveness Analyses: A Role for Social Determinants of Health?
    Raley E; Jefferson AA
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1948-1949. PubMed ID: 33966871
    [No Abstract]   [Full Text] [Related]  

  • 91. [Tiotropium in asthma poorly controlled with standard combination therapy].
    Aparicio González T
    Rev Clin Esp (Barc); 2013 Mar; 213(2):115. PubMed ID: 23607109
    [No Abstract]   [Full Text] [Related]  

  • 92. Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside.
    Radovanovic D; Santus P; Blasi F; Mantero M
    Multidiscip Respir Med; 2017; 12():17. PubMed ID: 28593046
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.
    Kerstjens HA; Casale TB; Bleecker ER; Meltzer EO; Pizzichini E; Schmidt O; Engel M; Bour L; Verkleij CB; Moroni-Zentgraf P; Bateman ED
    Lancet Respir Med; 2015 May; 3(5):367-76. PubMed ID: 25682232
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
    Kew KM; Evans DJ; Allison DE; Boyter AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data.
    Abadoglu O; Berk S
    Clin Respir J; 2016 Jul; 10(4):421-7. PubMed ID: 25335652
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):211-6. PubMed ID: 26231467
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide.
    Price D; Kaplan A; Jones R; Freeman D; Burden A; Gould S; von Ziegenweidt J; Ali M; King C; Thomas M
    J Asthma Allergy; 2015; 8():1-13. PubMed ID: 25609985
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-acting anticholinergic agents in patients with uncontrolled asthma: a systematic review and meta-analysis.
    Lee SW; Kim HJ; Yoo KH; Park YB; Park JY; Jung JY; Moon JY; Byun MK; Kim SW; Kim YH
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1421-30. PubMed ID: 25517806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.